These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 18580502

  • 1. Effect of stimulants on height and weight: a review of the literature.
    Faraone SV, Biederman J, Morley CP, Spencer TJ.
    J Am Acad Child Adolesc Psychiatry; 2008 Sep; 47(9):994-1009. PubMed ID: 18580502
    [Abstract] [Full Text] [Related]

  • 2. Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?
    Spencer TJ, Biederman J, Harding M, O'Donnell D, Faraone SV, Wilens TE.
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1460-9. PubMed ID: 8936912
    [Abstract] [Full Text] [Related]

  • 3. Long-term effects of short-acting methylphenidate on growth rates of children with attention deficit hyperactivity disorder at Queen Sirikit National Institute of Child Health.
    Moungnoi P, Maipang P.
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S158-63. PubMed ID: 22043770
    [Abstract] [Full Text] [Related]

  • 4. Stimulant treatment over 5 years: effects on growth.
    Charach A, Figueroa M, Chen S, Ickowicz A, Schachar R.
    J Am Acad Child Adolesc Psychiatry; 2006 Apr; 45(4):415-21. PubMed ID: 16601646
    [Abstract] [Full Text] [Related]

  • 5. Does extended medication with amphetamine or methylphenidate reduce growth in hyperactive children?
    Sund AM, Zeiner P.
    Nord J Psychiatry; 2002 Apr; 56(1):53-7. PubMed ID: 11869467
    [Abstract] [Full Text] [Related]

  • 6. Growth deficits in children with attention deficit hyperactivity disorder.
    Spencer T, Biederman J, Wilens T.
    Pediatrics; 1998 Aug; 102(2 Pt 3):501-6. PubMed ID: 9685453
    [Abstract] [Full Text] [Related]

  • 7. Growth and sexual maturation in children and adolescents with attention deficit hyperactivity disorder.
    Poulton A.
    Curr Opin Pediatr; 2006 Aug; 18(4):427-34. PubMed ID: 16914999
    [Abstract] [Full Text] [Related]

  • 8. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA, Pliszka SR.
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [Abstract] [Full Text] [Related]

  • 9. Impact of long-term treatment of methylphenidate on height and weight of school age children with ADHD.
    Zhang H, Du M, Zhuang S.
    Neuropediatrics; 2010 Aug; 41(2):55-9. PubMed ID: 20799150
    [Abstract] [Full Text] [Related]

  • 10. Growth on stimulant medication; clarifying the confusion: a review.
    Poulton A.
    Arch Dis Child; 2005 Aug; 90(8):801-6. PubMed ID: 16040876
    [Abstract] [Full Text] [Related]

  • 11. Growth deficits in children treated with desipramine: a controlled study.
    Spencer T, Biederman J, Wright V, Danon M.
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):235-43. PubMed ID: 1564024
    [Abstract] [Full Text] [Related]

  • 12. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication.
    Schertz M, Adesman AR, Alfieri NE, Bienkowski RS.
    Pediatrics; 1996 Oct; 98(4 Pt 1):763-9. PubMed ID: 8885958
    [Abstract] [Full Text] [Related]

  • 13. Effects of long-term psychostimulant medication on growth of children with ADHD.
    Zachor DA, Roberts AW, Hodgens JB, Isaacs JS, Merrick J.
    Res Dev Disabil; 2006 Oct; 27(2):162-74. PubMed ID: 15955659
    [Abstract] [Full Text] [Related]

  • 14. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P.
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [Abstract] [Full Text] [Related]

  • 15. Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.
    Merkel RL, Kuchibhatla A.
    Expert Opin Drug Saf; 2009 Nov; 8(6):655-68. PubMed ID: 19785509
    [Abstract] [Full Text] [Related]

  • 16. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B, Sopko MA, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [Abstract] [Full Text] [Related]

  • 17. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ, Merkel RL, Moore M, Thorndike F, Muller C, Kovatchev B.
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [Abstract] [Full Text] [Related]

  • 18. Effects of osmotic-release methylphenidate on height and weight in children with attention-deficit hyperactivity disorder (ADHD) following up to four years of treatment.
    Durá-Travé T, Yoldi-Petri ME, Gallinas-Victoriano F, Zardoya-Santos P.
    J Child Neurol; 2012 May; 27(5):604-9. PubMed ID: 22190507
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.